About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Well, Sonny, That's Not How We Did It | Main | Let's See What the Sharks Think of These Steaks! »

November 1, 2004

Now With The Great Taste of Fish

Email This Entry

Posted by Derek

You'll notice a new design here this morning - the Corantean Heirarchy is switching everyone over to a newer template. You can now adjust the text size, for example, which is something I know a lot of people have asked for (in both directions.) And if you get the blog by e-mail, you can now subscribe to specific categories of posts (or, more to the point I suppose, specifically leave some categories out!)

Let me know how things are working, and if you have some other features that you'd like to see. Other than the content of the posts, anyway - unfixable, that is.

Comments (5) + TrackBacks (0) | Category: Blog Housekeeping


1. Linkmeister on November 1, 2004 2:52 PM writes...

So when is Corante going to restart its own page of digested posts on its main page?

Permalink to Comment

2. steve on November 1, 2004 7:33 PM writes...

The new format is very bad using IE on a Mac OS 9.2. The text on the right runs into and is obscured by all the frames, etc. on the right of the screen.

Permalink to Comment

3. JSinger on November 2, 2004 10:01 AM writes...

Same issue as Steve, but with IE on Windows XP. Collision between the right frame and the main text, especially on the front page.

Also, placing a paragraph break before "Permalink to Comment" would greatly help comment readability.

Preview is a huge advance, though!!

Permalink to Comment

4. bago on November 4, 2004 10:01 PM writes...

You need to specifically set the background color of the page to white. Not everyone uses default windows schemes.

Permalink to Comment

5. richard moore on November 8, 2004 10:52 AM writes...

I miss the links section to other blogs especially to medical/science blogs. Did corante make you get rid of this service? Can you bring it back? RM

Permalink to Comment


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry